You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
景峯醫藥(000908.SZ)擬3.2億元轉讓海門慧聚43%股權
格隆匯 05-11 16:27

格隆匯5月11日丨景峯醫藥(000908.SZ)公佈,公司子公司上海景峯製藥有限公司(下稱“上海景峯”)將所持有的海門慧聚藥業有限公司(下稱“海門慧聚”)43.0086%股權(下稱“標的股權”)參考評估價值作價3.2億元轉讓給湖州富悦柏澤實業投資合夥企業(有限合夥)(下稱“富悦柏澤”)和湖州富悦信澤實業投資合夥企業(有限合夥)(下稱“富悦信澤”),其中富悦柏澤受讓34.0441%,富悦信澤受讓8.9645%。

公司擬通過本次部分股權轉讓將各方利益結合在一起,建立健全長效激勵機制,共同關注海門慧聚的長遠發展。本次交易完成後,上海景峯對海門慧聚的持股比例將由63.0086%變更為20.00%,將不再納入公司合併報表範圍。2020年5月8日,上海景峯與富悦柏澤和富悦信澤簽署了《關於海門慧聚藥業有限公司之股權轉讓協議》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account